Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Gentian Diagnostics ASA ( (DE:6FK) ) has issued an announcement.
Gentian Diagnostics ASA announced that its CEO, Matti Heinonen, has purchased 5,000 shares of the company at a price of NOK 54.86 per share, increasing his total holdings to 5,000 shares and 100,000 options. This transaction, disclosed in compliance with EU Market Abuse Regulation and Norwegian Securities Trading Act, may signal confidence in the company’s future prospects and could influence investor sentiment.
More about Gentian Diagnostics ASA
Average Trading Volume: 7,780
Current Market Cap: NOK817.4M
Find detailed analytics on 6FK stock on TipRanks’ Stock Analysis page.